KMA and Co.
  • Why
  • Who
  • What
  • Where
  • Case Studies
  • Thought Leadership
  • Blog
Select Page
Digital Therapeutic Deals in a Time of COVID-19

Digital Therapeutic Deals in a Time of COVID-19

by Cassie Arnold | Apr 21, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment

First quarter digital therapeutic deal data provided by DealForma shows a drop quarter-over-quarter from 16 transactions in the last quarter of 2019 to 11 in the first quarter of 2020. But year-over-year, the first quarter of 2020 is on par with the first quarter of...

Recent Posts

  • Five Bits of Advice on MarCom Tactics
  • TL;DR*, Less is More, Short and Sweet
  • Digital Therapeutic Investment Soars — is there a bubble in our future?
  • Digital Therapeutics is Primed for a Return to the Roaring 20’s
  • In a Time of COVID, Dealmakers Take a Shine to Diagnostics and Vaccines

Archives

  • March 2022
  • August 2021
  • July 2021
  • April 2021
  • February 2021
  • January 2021
  • November 2020
  • August 2020
  • July 2020
  • April 2020
  • February 2020
  • November 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • March 2018
  • February 2018
  • November 2017
  • May 2017
  • March 2017
  • January 2017
  • September 2016
  • August 2016
  • April 2016
  • March 2016
  • February 2016
  • December 2015
  • October 2015
  • June 2015
  • April 2015
  • March 2015
  • February 2015
  • November 2014
  • October 2014
  • August 2014
  • June 2014

Categories

  • 21st Century Culture
  • Advertising
  • Biotech Finance
  • Branding
  • Communications
  • COVID
  • Deal making
  • Digital Health
  • Digital Therapeutic
  • Digital Therapeutics
  • Gender at Work
  • Investment
  • Modern Work
  • Persuasion
  • Sales
  • Uncategorized
  • Venture capital
  • Twitter
  • RSS
© 2021 KMA & Company